CoChat

The USP 8 mutational status may predict long‐term remission in patients with Cushing's disease

Albani, Adriana, Pérez‐Rivas, Luis G., Dimopoulou, Christina, Zopp, Stephanie, Colón‐Bolea, Paula, Roeber, Sigrun, Honegger, Jürgen, Flitsch, Jörg, Rachinger, Walter, Buchfelder, Michael, Stalla, Günter K., Herms, Jochen, Reincke, Martin, Theodoropoulou, Marily · 2018 · Clinical Endocrinology
Cited by 84

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary: Objective: Almost half of the cases of Cushing's disease (CD) tumours carry recurrent activating somatic mutations in the ubiquitin‐specific protease eight gene (USP 8). The USP 8 mutational status could predict remission in patients with CD, so our objective was to correlate the presence of somatic USP 8 mutations with the rate of recurrence after transsphenoidal surgery (TSS) retrospectively. Design: Biochemical, radiological and clinical data were retrospectively assessed in 48 patients. USP 8 mutational status was determined from corticotroph tumour samples. Association between USP 8 mutational status, remission and recurrence was investigated. Patients: Patients with Cushing's disease from a single‐centre cohort who underwent TSS between 1991 and 2012. Measurements: Long‐term remission and recurrence rate after TSS with at least 6 months follow‐up. Biochemical, radiological and clinical data, including sex, age at diagnosis, tumour size and pre‐operative hormonal levels. USP 8 mutational status. Results: Patients with USP 8 mutant corticotroph tumours (18 of 48; 37%) were diagnosed significantly earlier (mean ± SD 46 ± 10 years vs 53 ± 11 years; P = 0.028) and presented with higher pre‐operative 24‐hour urinary‐free cortisol levels (median IQR μg/24 hours 1174.0, 1184.5 vs 480.0, 405.3; P = 0.045). The incidence of recurrence in a 10‐year follow‐up was significantly higher in patients with USP 8 mutant tumours after the initial remission (58% vs 18% P = 0.026). Recurrence appeared significantly earlier in these patients (months 70, 44‐97 95% CI vs 102, 86‐119 95% CI; P = 0.019). Conclusion: Recurrence appears to be more frequent and earlier after TSS in patients with USP 8 mutant corticotroph tumours.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cen.13802

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Albani, A., Pérez‐Rivas, L. G., Dimopoulou, C., Zopp, S., Colón‐Bolea, P., Roeber, S., Honegger, J., Flitsch, J., Rachinger, W., Buchfelder, M., Stalla, G. K., Herms, J., Reincke, M., & Theodoropoulou, M.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2018-07-23
Volume
89
Issue
4
Pages
454-458
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2809742082
Cited by
84
References
3
FWCI
5.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.